Beeline Medicines
- Health & Biotech
- Stamford, Connecticut, US
- Founded 2025
- Private
- beelinemedicines.com
Biotech developing precision therapies for autoimmune and inflammatory diseases, built around five immunology assets from Bristol Myers Squibb.
$426MEquity raised in 2025–20262025 — · 2026 $426M · 1 equity round
$426MEquity raised, all time1 equity round on record
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 3 sources
- Series AAmount$426MPost-money—✓ Confirmed
Investors 3
- Bain Capital1
- Bristol Myers Squibb
- CPP Investments
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
Kailera TherapeuticsHealth · $600M in 2025–2026Shared: Bain Capital, CPP InvestmentsKahuaEnterprise · $250M in 2025–2026Shared: Bain CapitalLegoraAI Apps · $1.3B in 2025–2026Shared: Bain CapitalOratomicDeep Tech · $775M in 2025–2026Shared: Bain CapitalPathos AIHealth · $602M in 2025–2026Shared: Bristol Myers SquibbCoralogixEnterprise · $315M in 2025–2026Shared: CPP Investments
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Beeline Medicines and its logo are trademarks of their owners, used here for identification only.
